PDR brachytherapy with flexible implants for interstitial boost after breast-conserving surgery and external beam radiation therapy

Radiotherapy and Oncology

Volumn 45, Issue 1, 1997, Pages 23-32

  Fritz, Peter ^a,b   Berns, Christiane ^a   Anton, Hans Werner ^a   Hensley, Frank ^a   Assman, Jörg ^a   Flentje, Michael ^a   Von Fournier, Dietrich ^a   Wannenmacher, Michael ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

Brachytherapy; Breast cancer; Interstitial boost; Pulsed dose rate

Indexed keywords

ANTINEOPLASTIC AGENT; HORMONE; IRIDIUM 192; TAMOXIFEN;

ADULT; AGED; ARTICLE; BEAM THERAPY; BRACHYTHERAPY; BREAST CANCER; BREAST ENDOPROSTHESIS; CANCER ADJUVANT THERAPY; CLINICAL TRIAL; DOSE CALCULATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MORBIDITY; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; TREATMENT OUTCOME; TREATMENT PLANNING;

ADULT; AGED; BRACHYTHERAPY; BREAST NEOPLASMS; DISEASE-FREE SURVIVAL; DOSE-RESPONSE RELATIONSHIP, RADIATION; ESTHETICS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MASTECTOMY, SIMPLE; MIDDLE AGED; PROGNOSIS; RADIOTHERAPY DOSAGE; RADIOTHERAPY, ADJUVANT; SURVIVAL RATE;

EID: 0030769901     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-8140(97)00145-X     Document Type: Article

References (40)

1. Anderson, L.L. A 'natural' volume-dose histogram for brachytherapy. Med. Phys. 13: 898-903, 1986.
2. Armour, E., Wang, Z., Corry, P. and Martinez, A. Equivalence of continuous and pulse simulated low dose rate irradiation in 9 L gliosarcoma cells at 37° and 41°C. Int. J. Radiat. Oncol. Biol. Phys. 22: 109-114, 1992.
3. Berns, C., Fritz, P., Hensley, F.W. and Wannenmacher, M. Consequences of optimization in PDR-brachytherapy - is a routine geometrical optimization recommendable? Int. J. Radiat. Oncol. Biol. Phys. 37: 1171-1180, 1997.
4. Borger, J.H., Kemperman, H., Smitt, H.S., Hart, A., van Dongen, J., Lebesque, J. and Bartelink, H. Dose and volume effects on fibrosis after breast conservation therapy. Int. J. Radiat. Oncol. Biol. Phys. 30: 1073-1081, 1994.
5. Boyages, J., Bilous, M., Barraclough, B. and Langlands, A.O. Fat necrosis of the breast following lumpectomy and radiation therapy for early breast cancer. Radiother. Oncol. 13: 69-74, 1988.
6. Brenner, D.J. and Hall, E.J. Conditions for the equivalence of continuous to pulsed low dose rate brachytherapy. Int. J. Radiat. Oncol. Biol. Phys. 20: 181-190, 1991.
7. Calle, R., Pilleron, J.P., Schlienger, P. and Vilcoq, J.R. Conservative management of operable breast cancer: ten years experience at the Foundation Curie. Cancer 42: 2045-2053, 1978.
8. Clarke, D.H. Identification of a high risk subset of patients undergoing breast conservation therapy who may benefit from more aggressive local therapy. In: Brachytherapy HDR and LDR, pp. 231-250. Editors: A.A. Martinez, C.G. Orton and R.F. Mould. Nucletron Corporation, Columbia, OH; Nucletron International, Leersum, 1990.
9. Clarke, D.H., Vincini, F., Jacobs, H., Rowland, C.G. and Kuske, R.R. High dose rate brachytherapy for breast cancer. In: High Dose Rate Brachytherapy: A Textbook, pp. 321-329. Editor: S. Nag. Futura Publishing Company, Armonk, NY, 1994.
10. Deore, S.M., Sarin, R., Dinshaw, K.A. and Shrivastava, S.K. Influence of dose-rate and dose per fraction on clinical outcome of breast cancer treated by external beam irradiation plus iridium-192 implants: analysis of 289 cases. Int. J. Radiat. Oncol. Biol. Phys. 26: 601-606, 1993.
11. Dutreix, A., Marinello, G. and Wambersie, A. The Paris System. In: Dosimétrie en Curiethérapie. Masson, Paris, 1982.
12. Fournier von, D. and Anton, H.W. Mammakarzinom: Ergebnisse der brusterhaltenden Behandlung [Breast cancer: results of breast saving treatment]. Ther. Umsch. 50: 339-343, 1993.
13. Fournier von, D., Kubli, F., Bastert, G., Engel, K., Anton, H.W. and Müller, A. [Breast saving treatment of breast cancer: results, risks, new developments] Die brusterhaltende Behandlung des Mammakarzinoms: Ergebnisse, Risiken, neue Entwicklungen. Geburtshilfe-Frauenheilkd. 51: 959-968, 1991.
14. Fowble, B., Solin, L.J., Schultz, D.J., Rubenstein, J. and Goodman, R.L. Breast recurrence following conservative surgery and radiation: patterns of failure, prognosis, and pathologic findings from mastectomy specimens with implications for treatment. Int. J. Radiat. Oncol. Biol. Phys. 19: 833-842, 1990.
15. Fowler, J. and Mount, M. Pulsed brachytherapy: the conditions for not significant loss of therapeutic ratio compared with traditional low dose rate brachytherapy. Int. J. Radiat. Oncol. Biol. Phys. 23: 661-669, 1992.
16. Fritz, P., Hensley, F.W., Berns, C., Schraube, P. and Wannenmacher, M. First experiences with superfractionated skin irradiations using large afterloading molds. Int. J. Radiat. Oncol. Biol. Phys. 36: 147-157, 1996.
17. Fritz, P., Weber, K.J., Frank, C. and Flentje, M. Differential effects of dose rate and superfractionation on survival and cell cycle of V79 cells from spheroid and monolayer culture. Radiother. Oncol. 39: 73-79, 1996.
18. Habibollahi, F., Mayles, H.M., Mayles, W.P., Winter, P.J., Tong, D., Fentiman, I.S., Chaudary, M.A. and Hayward, J.L. Assessment of skin dose and its relation to cosmesis in the conservative treatment of early breast cancer. Int. J. Radiat. Oncol. Biol. Phys. 14: 291-296, 1988.
19. Hammer, J., Seewald, D.H., Track, C., Zoidl, J.P. and Labeck, W. Breast cancer primary treatment with external-beam radiation therapy and high-dose-rate iridium implantation. Radiology 193: 573-577, 1994.
20. Kolkman-Deurloo, I.K.K., Visser, A.G., Niel, C.G.J.H., Driver, N. and Levendag, P.C. Optimization of interstitial volume implants. Radiother. Oncol. 31: 229-239, 1994.
21. Krishnan, L., Jewell, W.R., Krishnan, E.C., Cherian, R. and Lin, F. Breast cancer with extensive intraductal component: treatment with immediate interstitial boost irradiation. Radiology 183: 273-276, 1992.
22. Krishnan, L., Jewell, W.R., Mansfield, C.M., Reddy, E.K., Thomas, J.H. and Krishnan, E.C. Early-stage breast cancer: local control after conservative surgery and radiation therapy with immediate interstitial boost. Radiology 187: 95-98, 1993.
23. Krishnan, L., Mansfield, C.M., Jewell, W.R., Reddy, E.K., Thomas, J.H. and Krishnan, E.C. Breast conservation treatment with perioperative interstitial irradiation. Am. J. Clin. Oncol. 10: 383-386, 1987.
24. Lea, C.E. and Catcheside, D.G. The mechanism of the induction by radiation of chromosome aberrations in tradescantia. J. Genet. 44: 216-245, 1942.
25. Mason, K.A., Thames, H.D., Ochran, T. and Janjan, N. Pulsed and continuous low-dose rate brachytherapy: biological equivalence in vivo (abstract). Int. J. Radiat. Oncol. Biol. Phys. 27: 144, 1993.
26. Mazeron, J.J., Simon, J.-M., Crook, J., Calitchi, E., Otmezguine, Y., Le Bourgeois, J.-P. and Pierquin, B. Influence of dose rate on local control of breast carcinoma treated by external beam irradiation plus iridium 192 implant. Int. J. Radiat. Oncol. Biol. Phys. 21: 1173-1177, 1991.
27. Mazeron, J.J., Boisserie, G., Gokarn, N. and Baillet, F. Pulsed LDR brachytherapy, current clinical status, Paris, France. Activity (International Nucletron Radiotherapy Journal) Special Report No. 5: 24-28, 1994.
28. McRae, D., Rodgers, J. and Dritschilo, A. Dose-volume and complication in interstitial implants for breast carcinoma. Int. J. Radiat. Oncol. Biol. Phys. 13: 525-529, 1987.
29. Montbarbon, X., Ardiet, J.M., Chassard, J.L., Gerard, J.P., Lacroze, M., Romestaing, P., Mornex, F., Carrie, C., Dutou, L., Montbarbon, J.F. et al. [Conservative treatment of breast cancer (the Lyon experience during 1963-1983)]. Traitement conservateur du cancer du sein (experience lyonnaise 1963-1983). Bull. Cancer Paris 77: 917-923, 1990.
30. Pierquin, B., Chassagne, D. and Perez, R. Précis de Curiethérapie. Masson, Paris, 1964.
31. Pierquin, B. and Heart, J. Experience with breast conserving approaches at the Hospital Henri Mondor. In: Primary Management of Breast Cancer, pp. 80-101. Editors: J.S. Tobias and M.J. Peckham. Arnold, London, 1985.
32. Puthawala, A.A., Syed, A.M.N., Sheikh, K.M.A., Gowdy, R.A. and McNamara, C.S. Combined external and interstitial irradiation in the treatment of stage III breast cancer. Radiology 153: 813-816, 1984.
33. Rathmell, A.J. and Ash, D.V. Radiotherapy after conservative surgery for breast cancer: selective use of iridium-192 wire boost to tumour bed in high risk patients. Clin. Oncol. R. Coll. Radiol. 3: 204-208, 1991.
34. Recht, A., Silver, B., Schnitt, S., Connolly, J., Hellman, S. and Harris, J.R. Breast relapse following primary therapy for early breast cancer. I. Classification, frequency and salvage. Int. J. Radiat. Oncol. Biol. Phys. 11: 1271-1276, 1985.
35. UICC: TNM Atlas. Illustrated Guide to the TNM/pTNM Classification of Malignant Tumours, 3rd edn., 2nd revision. Springer-Verlag, Berlin, 1992.
36. Sauer, R. and Strnad, V. Strahlentherapie beim operablen Mammakarzinom. Forum DKG 9: 28-44, 1994.
37. van der Laarse, R. The stepping source dosimetry system as an extension of the Paris system. In: Brachytherapy from Radium to Optimization, pp. 319-330. Editors: R.F. Mould, J.J. Battermann, A.A. Martinez and B.L. Speiser. Nucletron International, Veenendaal, The Netherlands, 1994.
38. van der Laarse, R. and Prins, T.P.E. Volume-dose histogramms. In: International Brachytherapy, pp. 270-273. Editor: R.F. Mould. Nucletron International, Veenendaal, The Netherlands, 1992.
39. van der Laarse, R. and Prins, T.P.E. Introduction to HDR brachytherapy optimisation. In: Brachytherapy from Radium to Optimization, pp. 331-351. Editors: R.F. Mould, J.J. Battermann, A.A. Martinez and B.L. Speiser. Nucletron International, Veenendaal, The Netherlands, 1994.
40. van der Laarse, R. and Prins, T.P.E. Comparing the stepping source dosimetry system and the Paris system using volume-dose histograms of breast implants. In: Brachytherapy from Radium to Optimization, pp. 352-372. Editors: R.F. Mould, J.J. Battermann, A.A. Martinez and B.L. Speiser. Nucletron International, Veenendaal, The Netherlands, 1994.